Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. 1997

A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India.

Arterial thrombosis is the most frequent major complication of percutaneous arterial catheterization in children. We prospectively studied the effect of randomized dosage of heparin, 50 IU/kg-group I and 100 IU/kg-group II, on the incidence of arterial thrombosis in 366 children and analysed the various factors which may influence the occurrence of this complication. The age of patients ranged from 17 d to 11 yr (mean age 39.5 +/- 40.9 mo) and mean weight was 11.2 +/- 7.8 kg (range 3 to 39 kg). The incidence of arterial thrombosis was 9.8% in group I and 9.3% in group II (P = NS). There was no statistical difference in precatheterization and procedure variables in the two groups and also in the group with absent pulse (n = 35) to the group with pulse present post cath (n = 331). There were 24.9% infants in our study and 14.3% of these had arterial thrombosis. The loss of pulse was more often seen with more number of attempts at arterial puncture (P < 0.001), absence of back bleed at the end of the procedure (P < 0.001), and increased duration of catheterization (P < 0.01). Use of larger sheath size in a given weight and body surface area of children increased incidence of arterial thrombosis. The administration of heparin 50 IU/kg was equally efficacious to heparin 100 IU/kg. Of the patients with arterial thrombosis, 23 responded with intravenous heparin and 12 needed streptokinase. There was no bleeding or haematoma. Thus our study shows that less attempt for arterial puncture, use of smaller sheath size, maintaining shortest procedure time and ensuring back bleed minimises incidence of arterial thrombosis post catheterization.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005263 Femoral Artery The main artery of the thigh, a continuation of the external iliac artery. Common Femoral Artery,Arteries, Common Femoral,Arteries, Femoral,Artery, Common Femoral,Artery, Femoral,Common Femoral Arteries,Femoral Arteries,Femoral Arteries, Common,Femoral Artery, Common
D005544 Forecasting The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. Futurology,Projections and Predictions,Future,Predictions and Projections
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
August 1986, The American journal of cardiology,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
January 1979, Catheterization and cardiovascular diagnosis,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
March 2014, The Cochrane database of systematic reviews,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
February 2020, The Cochrane database of systematic reviews,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
January 1987, Acta radiologica (Stockholm, Sweden : 1987),
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
September 1974, Circulation,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
March 1974, American heart journal,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
March 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
February 2014, Research in cardiovascular medicine,
A Saxena, and R Gupta, and R K Kumar, and S S Kothari, and H S Wasir
June 2015, Heart (British Cardiac Society),
Copied contents to your clipboard!